These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 4150017

  • 1. The effect of beta-adrenergic blocking agents on the rat adrenal phenylethanolamine-N-methyltransferase activity.
    Janiec W, Lukas W, Glogowski A.
    Pol J Pharmacol Pharm; 1973; 25(3):237-41. PubMed ID: 4150017
    [No Abstract] [Full Text] [Related]

  • 2. Effect of beta-adrenergic blocking agents on the spontaneous motility of mice.
    Fabian HE, Izquierdo JA.
    Arzneimittelforschung; 1972 Aug; 22(8):1375-6. PubMed ID: 4404659
    [No Abstract] [Full Text] [Related]

  • 3. Importance of the aromatic ring in adrenergic amines. Nonaromatic analoques of phenylethanolamine as substrates for phenylethanolamine N-methyltransferase.
    Grunewald GL, Grindel JM, Vincek WC, Borchardt RT.
    Mol Pharmacol; 1975 Sep; 11(5):694-9. PubMed ID: 1237082
    [No Abstract] [Full Text] [Related]

  • 4. Protection against isoprenaline induced myocardial necroses by beta-adrenergic blocking agents.
    Kulig A, Kostka-Trabka E, Gryglewski R.
    Pol J Pharmacol Pharm; 1973 Sep; 25(1):85-90. PubMed ID: 4149575
    [No Abstract] [Full Text] [Related]

  • 5. Position of a chloro substituent on phenylethanolamine as a determinant of methylation by rabbit adrenal norepinephrine N-methyltransferase.
    Fuller RW, Hemrick SK, Molloy BB.
    Res Commun Chem Pathol Pharmacol; 1977 Nov; 18(3):577-80. PubMed ID: 928956
    [No Abstract] [Full Text] [Related]

  • 6. Inhibition of brain epinephrine synthesis by 3,4-dichlorophenylethanolamine, a competitive substrate for norepinephrine N-methyltransferase.
    Fuller RW, Hemrick-Luecke SK, Perry KW.
    Biochem Pharmacol; 1983 Jan 15; 32(2):215-20. PubMed ID: 6870951
    [No Abstract] [Full Text] [Related]

  • 7. The binding order of substrates to phenylethanolamine N-methyltransferase.
    Pendleton RG, Snow IB.
    Mol Pharmacol; 1973 Nov 15; 9(6):718-25. PubMed ID: 4762633
    [No Abstract] [Full Text] [Related]

  • 8. The remarkable substrate activity for phenylethanolamine N-methyltransferase of some conformationally defined phenylethylamines lacking a side-chain hydroxyl group. Conformationally defined adrenergic agents. 6.
    Rafferty MF, Grunewald GL.
    Mol Pharmacol; 1982 Jul 15; 22(1):127-32. PubMed ID: 7121446
    [No Abstract] [Full Text] [Related]

  • 9. [Effect of substance P on dopamine-beta-hydroxylase and phenethanolamine-N-methyltransferase in the adrenal glands of rats].
    Piesche L, Oehme P, Hilse H, Hecht K.
    Pharmazie; 1982 Aug 15; 37(8):591-3. PubMed ID: 6183680
    [Abstract] [Full Text] [Related]

  • 10. Effect of intraperitoneal administration of (+)-INPEA on oxytocin and prostaglandin evoked responses of the isolated rat uterus.
    Rao VS, Sharma PL.
    Br J Pharmacol; 1973 Jun 15; 48(2):344P-345P. PubMed ID: 4147431
    [No Abstract] [Full Text] [Related]

  • 11. Regulation of phenylethanolamine N-methyltransferase synthesis and degradation. I. Regulation by rat adrenal glucocorticoids.
    Ciaranello RD.
    Mol Pharmacol; 1978 May 15; 14(3):478-89. PubMed ID: 351371
    [No Abstract] [Full Text] [Related]

  • 12. Regulation of synthesis and degradation of rat adrenal phenylethanolamine N-methyltransferase. III. Stabilization of PNMT against thermal and tryptic degradation by S-adenosylmethionine.
    Berenbeim DM, Wong DL, Masover SJ, Ciaranello RD.
    Mol Pharmacol; 1979 Sep 15; 16(2):482-90. PubMed ID: 514254
    [No Abstract] [Full Text] [Related]

  • 13. Studies on SK and F 7698; an inhibitor of phenylethanolamine N-methyltransferase (PNMT).
    Pendleton RG, Kaiser C, Gessner G, Finlay E, Green H.
    J Pharmacol Exp Ther; 1974 Sep 15; 190(3):551-62. PubMed ID: 4415962
    [No Abstract] [Full Text] [Related]

  • 14. Methylation of non-phenyl ethanolamines by norepinephrine N-methyltransferase.
    Fuller RW, Roush BW.
    Res Commun Chem Pathol Pharmacol; 1977 Aug 15; 17(4):727-30. PubMed ID: 897354
    [No Abstract] [Full Text] [Related]

  • 15. Heterogeneity of N-and O-methyltransferases.
    Axelrod J, Vesell ES.
    Mol Pharmacol; 1970 Jan 15; 6(1):78-84. PubMed ID: 5527525
    [No Abstract] [Full Text] [Related]

  • 16. Central actions of some beta-adrenoceptor blocking agents.
    Shah UH, Jindal MN, Patel VK, Kelkar VV.
    Arzneimittelforschung; 1974 Oct 15; 24(10):1581-4. PubMed ID: 4154760
    [No Abstract] [Full Text] [Related]

  • 17. Regulation of phenylethanolamine N-methyltransferase synthesis and degradation. II. Control of the thermal stability of the enzyme by an endogenous stabilizing factor.
    Ciaranello RD, Wong DL, Berenbeim DM.
    Mol Pharmacol; 1978 May 15; 14(3):490-501. PubMed ID: 207972
    [No Abstract] [Full Text] [Related]

  • 18. Catecholamine metabolism in pargyline treated rats exposed to stress.
    Prasad R, Patel V, Chansouria JP, Udupa KN.
    Endocrinol Exp; 1980 May 15; 14(2):147-50. PubMed ID: 6104592
    [Abstract] [Full Text] [Related]

  • 19. Comparison of o-octopamine and related phenylethanolamines as substrates for norepinephrine N-methyltransferase.
    Fuller RW, Hemrick-Luecke SK, Midgley JM.
    Res Commun Chem Pathol Pharmacol; 1981 Aug 15; 33(2):207-13. PubMed ID: 6795705
    [Abstract] [Full Text] [Related]

  • 20. Substrate and inhibitor kinetics of bovine phenylethanolamine-N-methyltransferase.
    Hoffman AR, Ciaranello RD, Axelrod J.
    Biochem Pharmacol; 1975 Feb 15; 24(4):544-6. PubMed ID: 1167462
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.